Obalon Therapeutics, Inc. (OBLN) Forms $4.32 Double Bottom; Lakeland Financial (LKFN)’s Sentiment Is 0.78

Obalon Therapeutics, Inc. (OBLN) formed double bottom with $3.93 target or 9.00% below today’s $4.32 share price. Obalon Therapeutics, Inc. (OBLN) has $75.81M valuation. The stock increased 1.17% or $0.05 during the last trading session, reaching $4.32. About 29,437 shares traded. Obalon Therapeutics, Inc. (NASDAQ:OBLN) has 0.00% since May 11, 2017 and is . It has underperformed by 11.55% the S&P500.

Lakeland Financial Corp (LKFN) investors sentiment decreased to 0.78 in Q4 2017. It’s down -0.24, from 1.02 in 2017Q3. The ratio fall, as 46 hedge funds increased or opened new equity positions, while 59 sold and trimmed positions in Lakeland Financial Corp. The hedge funds in our database now have: 17.67 million shares, up from 17.46 million shares in 2017Q3. Also, the number of hedge funds holding Lakeland Financial Corp in top ten equity positions was flat from 1 to 1 for the same number . Sold All: 9 Reduced: 50 Increased: 34 New Position: 12.

Monarch Capital Management Inc holds 3.45% of its portfolio in Lakeland Financial Corporation for 191,436 shares. Neumeier Poma Investment Counsel Llc owns 413,603 shares or 2.01% of their US portfolio. Moreover, Walthausen & Co. Llc has 1.16% invested in the company for 253,856 shares. The Texas-based Vaughan Nelson Investment Management L.P. has invested 0.48% in the stock. Segall Bryant & Hamill Llc, a Illinois-based fund reported 377,646 shares.

More news for Lakeland Financial Corporation (NASDAQ:LKFN) were recently published by: Globenewswire.com, which released: “Lakeland Financial Reports Record First Quarter Performance” on April 25, 2018. Nasdaq.com‘s article titled: “Lake City Bank Named to KBW Bank Honor Roll of High Performing Banks for the 7th Consecutive Year” and published on April 26, 2018 is yet another important article.

Lakeland Financial Corporation operates as the bank holding firm for Lake City Bank that provides various financial services in Indiana. The company has market cap of $1.23 billion. The firm offers various deposit products, including noninterest bearing deposits; interest-bearing checking, savings, and money market deposits; and NOW and demand deposits. It has a 21.83 P/E ratio. It also provides commercial and industrial loans, commercial real estate and multi-family residential loans, agri-business and agricultural loans, and other commercial loans; and consumer 1-4 family mortgage loans and other consumer loans.

Since January 1, 0001, it had 2 insider purchases, and 10 insider sales for $1.11 million activity.

The stock decreased 0.14% or $0.07 during the last trading session, reaching $48.68. About 37,862 shares traded. Lakeland Financial Corporation (LKFN) has risen 9.54% since May 11, 2017 and is uptrending. It has underperformed by 2.01% the S&P500.

Among 2 analysts covering Obalon Therapeutics (NASDAQ:OBLN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Obalon Therapeutics has $21 highest and $18 lowest target. $19.50’s average target is 351.39% above currents $4.32 stock price. Obalon Therapeutics had 2 analyst reports since October 31, 2016 according to SRatingsIntel. The stock of Obalon Therapeutics, Inc. (NASDAQ:OBLN) earned “Buy” rating by UBS on Monday, October 31. The stock has “Buy” rating by Stifel Nicolaus on Monday, October 31.

Lakeland Financial Corporation (NASDAQ:LKFN) Institutional Positions Chart